Navigating modern peptide synthesis requires absolute transparency and analytical precision. PX1 Research delivers third-party tested Selank backed by independent ISO 17025 laboratory verification, high-performance liquid chromatography, and lot-specific certificates of analysis.
Navigating modern peptide synthesis requires absolute transparency and analytical precision. PX1 Research delivers third-party tested Selank backed by independent ISO 17025 laboratory verification, high-performance liquid chromatography, and lot-specific certificates of analysis.
Third-party tested Selank refers to research-grade Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) whose purity (>98%), sequence identity, and endotoxin levels are independently verified by an accredited ISO 17025 analytical laboratory using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS), accompanied by a lot-specific Certificate of Analysis.
In experimental biology, relying solely on manufacturer-provided documentation introduces significant risk. Synthetic peptides can harbor synthesis side-products, deletion sequences, residual trifluoroacetic acid (TFA), or bacterial endotoxins if quality control is inadequate. Verifying purity through neutral, accredited laboratories guarantees that observed cellular or physiological responses in test models are directly attributable to the target peptide sequence rather than manufacturing contaminants.
When procurement specialists select high-purity Selank 5mg for laboratory evaluation, obtaining independent analytical confirmation protects trial reproducibility. High-grade research reagents must present clean chromatographic profiles without secondary absorbance peaks that indicate degradation or incomplete peptide chain elongation.
Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg). By appending a Pro-Gly-Pro tripeptide sequence to the C-terminus of tuftsin, researchers engineered a molecule with enhanced enzymatic stability and altered biological target affinity. Its full chemical sequence is L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolyl-glycyl-L-proline, possessing a molecular formula of C33H57N11O9 and a molecular mass of 751.9 g/mol.
The addition of the Pro-Gly-Pro motif protects the peptide against rapid degradation by serum peptidases, extending its half-life in physiological media compared to native tuftsin. This structural fortification makes Selank a valuable subject for investigating peptide stability, receptor interaction kinetics, and peptide-driven metabolic signaling.
Researchers analyzing the physical properties of Selank utilize solid-phase peptide synthesis (SPPS) protocols to yield high-purity lyophilized cakes. Understanding the exact primary structure is critical when interpreting quantitative binding assays or running structural studies using mass spectrometry techniques.
Preclinical investigations demonstrate that Selank acts primarily through the modulation of central neurotransmitter systems and neurotrophic factor expression. In vitro and rodent models indicate that Selank influences gamma-aminobutyric acid (GABA) ergic neurotransmission by modulating GABA-A receptor affinity, without binding directly to the classical benzodiazepine binding site. This indirect allosteric action is a major area of study regarding central nervous system signaling pathways.
Additionally, preclinical studies suggest that Selank modulates the expression of Brain-Derived Neurotrophic Factor (BDNF) and its primary tyrosine kinase receptor, TrkB, within the hippocampus. Rodent transcriptomic evaluations show that Selank exposure alters the expression of numerous genes involved in neurotransmission, ion channel function, and synaptic plasticity within hours of application.
Another key biochemical mechanism observed in vitro is the inhibition of enkephalin-degrading enzymes. By inhibiting carboxypeptidase N and Leu-enkephalin degradation in blood plasma, Selank prolongs the endogenous activity of enkephalins. These combined pathways provide a rich framework for preclinical research into stress response neurobiology, neuroinflammation models, and cognitive processes.
In the commercial peptide market, batch-to-batch variability remains a persistent challenge for academic and industrial researchers. A supplier claiming high purity must support those claims with transparent, batch-specific testing data performed by non-affiliated laboratories. In-house testing or static, generic Certificates of Analysis (COAs) do not provide the verification required for publication-grade research.
Independent ISO 17025 accredited testing facilities utilize stringent calibration standards to verify both peptide identity and concentration. By comparing liquid chromatography retention times against reference standards, these facilities confirm that the chemical identity matches the labeled sequence without batch cross-contamination.
Accessing comprehensive testing records through a centralized research repository allows investigators to perform rigorous pre-assay validation. Quality transparency ensures that experimental data generated across different study phases remains consistent and replicable.
To rigorously certify peptide quality, laboratories apply three primary analytical methodologies: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), Electrospray Ionization Mass Spectrometry (ESI-MS), and Limulus Amebocyte Lysate (LAL) endotoxin assays. Each technique addresses a specific parameter of chemical purity and biological safety.
RP-HPLC measures chemical purity by separating the primary peptide from synthesis impurities, truncated sequences, and deprotection byproducts. Utilizing C18 hydrophobic stationary phases and acetonitrile gradients with TFA ion-pairing reagents, RP-HPLC purity testing yields a UV absorbance chromatogram where the area under the main curve determines overall percentage purity—typically required to exceed 98.0% for analytical-grade applications.
Mass Spectrometry establishes precise molecular identity. ESI-MS measures the mass-to-charge ratio (m/z) of the ionized peptide molecule, confirming that the observed monoisotopic or average molecular weight matches the theoretical mass of Selank (751.9 Da). Finally, LAL endotoxin assays quantify lipopolysaccharide contamination, ensuring levels remain below strict thresholds (<0.1 EU/mg) to prevent non-specific inflammatory responses in cellular assays.
Unverified synthetic peptides often carry silent impurities that compromise experimental integrity. During solid-phase synthesis, incomplete coupling reactions can produce deletion peptides missing individual amino acids, such as des-proline or des-arginine variants. These contaminants often exhibit retention times similar to the target molecule, requiring high-resolution chromatography to detect.
Another frequent byproduct of crude synthesis is residual trifluoroacetic acid (TFA), used during cleavage from resin beds. If TFA counter-ions are not properly exchanged or reduced during purification, residual TFA can induce cytotoxicity in cell cultures and alter assay pH balance.
Failure to perform routine microbial and endotoxin testing introduces further risk of contaminating in vitro culture media. Researchers who utilize unverified materials risk generating skewed data, failing peer review, or wasting valuable laboratory resources on unrepeatable outcomes.
Within neurochemical and regulatory peptide research, Selank is frequently evaluated alongside other synthetic peptides developed for central nervous system investigations. Most notably, researchers compare Selank with Semax, an ACTH(4-10) analog designed to influence neurotrophic signaling and cholinergic function.
While both compounds demonstrate neuroprotective and gene-regulatory properties in animal models, their molecular mechanisms differ significantly. Selank primarily affects GABAergic system dynamics and enkephalinase inhibition, whereas Semax acts predominantly through melanocortin receptor interactions and brain-derived neurotrophic pathways. Studies utilizing modified derivatives such as N-Acetyl Semax Amidate highlight how acetylation and amidation alter peptide half-life and enzymatic stability in bio-fluid assays.
Evaluating these compounds side-by-side in controlled laboratory settings allows researchers to map distinct signaling pathways and dissect the structural factors governing regulatory peptide pharmacodynamics.
To preserve the structural integrity of third-party tested Selank, laboratory personnel must observe standard storage and handling guidelines. Lyophilized Selank powder should be stored at -20°C or -80°C upon receipt to prevent thermal degradation and moisture absorption. Under desiccated, sub-zero conditions, the lyophilized cake remains stable for extended periods.
When preparing Selank for experimental use, reconstitution should occur in an aseptic environment using sterile, laboratory-grade solvents such as bacteriostatic water or sterile 0.9% sodium chloride solution. Researchers should follow established reconstitution protocols to accurately calculate final target concentrations without degrading fragile peptide chains.
Reconstituted peptide solutions should be aliquoted into single-use polypropylene tubes to minimize freeze-thaw cycles, which can cause aggregation or mechanical shear. Liquid aliquots should be maintained at 2°C to 8°C for short-term experimentation or frozen at -80°C for long-term storage.
PX1 Research maintains rigorous quality assurance protocols to supply the scientific community with validated, research-grade peptides. Every lot of Selank distributed by PX1 is synthesized in cGMP-compliant US facilities and subjected to independent validation by accredited ISO 17025 testing laboratories.
Our analytical standards mandate that every batch undergo RP-HPLC purity analysis, ESI-MS identity testing, and chromogenic LAL endotoxin testing prior to release. Publicly accessible Certificates of Analysis are published per individual production lot, allowing researchers to review chromatograms, mass spectra, and quantitative purity scores directly.
Logistical efficiency is equally critical for preserving product stability. PX1 operates specialized distribution centers in California and Arizona, offering same-day dispatch for orders placed Monday through Friday before cut-off times, ensuring minimal transit time and temperature degradation during delivery.
Academic institutions, biotechnology enterprises, and clinical research organizations require reliable suppliers capable of supporting both small-scale screening and large-scale trial requirements. Obtaining pure research material with complete documentation is essential for regulatory compliance and scientific integrity.
PX1 Research provides institutional purchasing options, including specialized accounts for wholesale peptide procurement and bulk contract manufacturing. Our technical support team assists research managers with documentation, batch reservation, and custom analytical requests.
By establishing stringent quality controls and direct lot traceability, PX1 Research serves as a trusted partner for advanced peptide research across North America and global academic laboratories.
What defines third-party tested Selank?
Third-party tested Selank is research-grade peptide material that has been independently analyzed by an accredited, un-affiliated ISO 17025 laboratory using methods such as RP-HPLC and mass spectrometry to verify its identity, purity (>98%), and lack of endotoxin contamination.
What analytical methods verify Selank purity and molecular weight?
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) determines chemical purity percentage by measuring UV absorbance, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight (751.9 Da).
How should lyophilized Selank be stored in the laboratory?
Lyophilized Selank should be stored in a freezer at -20°C or -80°C in a desiccated container to preserve chemical stability. Reconstituted liquid aliquots should be stored at 2°C to 8°C for short-term use or frozen at -80°C to avoid repeated freeze-thaw cycles.
What is the primary mechanism of action observed for Selank in preclinical literature?
Preclinical research indicates Selank modulates GABA-A receptor affinity, alters gene expression of BDNF and TrkB receptors in hippocampal tissue, and inhibits enkephalin-degrading enzymes such as carboxypeptidase N.
How does Selank compare structurally to Semax?
Selank is a 7-amino acid analog of the peptide tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro), whereas Semax is an heptapeptide derived from ACTH(4-10). They target distinct neurochemical systems and pathways in cellular and rodent models.
What are acceptable endotoxin limits for research peptides?
For high-grade in vitro and in vivo research applications, endotoxin levels should ideally measure below 0.1 EU/mg, as determined by a chromogenic Limulus Amebocyte Lysate (LAL) assay, to prevent unwanted non-specific immune responses.
Why is trifluoroacetic acid (TFA) testing important in peptide quality control?
TFA is commonly used during solid-phase synthesis cleavage. Residual TFA can exert cytotoxic effects on cell cultures and alter buffer pH, making TFA content reduction and reporting vital for consistent experimental outcomes.
How can I access the COA for a specific batch of PX1 Selank?
Every product lot from PX1 includes a lot-specific Certificate of Analysis accessible on our website, containing raw RP-HPLC chromatograms, mass spec reports, and measured purity percentages.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.